1. Home
  2. HYFM vs CLGN Comparison

HYFM vs CLGN Comparison

Compare HYFM & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

N/A

Current Price

$0.84

Market Cap

4.5M

Sector

Industrials

ML Signal

N/A

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

N/A

Current Price

$4.01

Market Cap

5.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HYFM
CLGN
Founded
1977
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
5.2M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
HYFM
CLGN
Price
$0.84
$4.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.5K
★ 66.2K
Earning Date
11-11-2026
09-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $134,252,000.00
N/A
Revenue This Year
$54.93
N/A
Revenue Next Year
$5.31
$25.00
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.50
$0.26
52 Week High
$3.42
$4.78

Technical Indicators

Market Signals
Indicator
HYFM
CLGN
Relative Strength Index (RSI) 38.29 60.92
Support Level $0.81 $0.34
Resistance Level $1.06 $3.91
Average True Range (ATR) 0.07 0.39
MACD -0.00 -0.14
Stochastic Oscillator 8.67 39.23

Price Performance

Historical Comparison
HYFM
CLGN

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: